• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by CareMax Inc. (Amendment)

    2/14/23 8:31:29 AM ET
    $CMAX
    Hospital/Nursing Management
    Health Care
    Get the next $CMAX alert in real time by email
    SC 13G/A 1 p23-0280sc13ga.htm CAREMAX, INC.

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 13G/A
    Amendment No. 1
     
    Under the Securities Exchange Act of 1934
     
     
    CareMax, Inc.
    (Name of Issuer)
     
    Class A Common Stock, par value $0.0001 per share
    (Title of Class of Securities)
     
    14171W103
    (CUSIP Number)
     
    December 31, 2022
    (Date of event which requires filing of this statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:
     

    x Rule 13d-1(b)
    ¨ Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 7 Pages)

     

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 14171W10313G/APage 2 of 7 Pages

     

    1

    NAME OF REPORTING PERSON

    Eminence Capital, LP

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ☒

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    10,462,311

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    10,462,311

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    10,462,311

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    9.4%

    12

    TYPE OF REPORTING PERSON

    IA

             

     

     

     

    CUSIP No. 14171W10313G/APage 3 of 7 Pages

     

    1

    NAME OF REPORTING PERSON

    Ricky C. Sandler

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ☒

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    10,462,311

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    10,462,311

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    10,462,311

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    9.4%

    12

    TYPE OF REPORTING PERSON

    IN

             

     

     

    CUSIP No. 14171W10313G/APage 4 of 7 Pages

     

    Item 1(a). Name of Issuer
       
      The name of the issuer is CareMax, Inc. (the "Company").  

     

    Item 1(b). Address of Issuer's Principal Executive Offices
       
      The Company's principal executive offices are located at 1000 NW 57 Court, Suite 400, Miami, FL 33126.
       

    Item 2. Name of Person Filing:
       
     

    This statement is filed by Eminence Capital, LP, a Delaware limited partnership (“Eminence Capital”) and Ricky C. Sandler, a U.S. Citizen (“Mr. Sandler,” and together with Eminence Capital, the “Reporting Persons”).

       
     

    Eminence Capital serves as the management company or investment adviser to, and may be deemed to have shared voting and dispositive power over the shares of Class A Common Stock held by, various investment funds (the “Eminence Funds”) and separately managed accounts (the “Eminence SMAs,” and together with the Eminence Funds, the “Eminence Funds and SMAs”) under its management and control. The general partner of Eminence Capital is Eminence Capital GP, LLC, the sole managing member of which is Mr. Sandler.

       
     

    Mr. Sandler is the Chief Executive Officer of Eminence Capital and may be deemed to have shared voting and dispositive power with respect to the shares of Class A Common Stock held by the Eminence Funds and SMAs.

       
      The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13G of the Act, the beneficial owner of the shares of Class A Common Stock reported herein.

     

    Item 2(b). Address of Principal Business Office or, if None, Residence:
       
      The address of the principal business and principal office of Eminence Capital is 399 Park Avenue, 25th Floor, New York, NY  10022.  The business address of Mr. Sandler is 399 Park Avenue, 25th Floor, New York, NY  10022.

     

    Item 2(c). Citizenship
       
     

    Eminence Capital is a limited partnership organized under the laws of the State of Delaware. Mr. Sandler is a United States citizen.

     

    Item 2(d). Title of Class of Securities
       
      Class A Common Stock, $0.0001 par value (the "Class A Common Stock").

     

    Item 2(e). CUSIP Number
       
      14171W103

     

    CUSIP No. 14171W10313G/APage 5 of 7 Pages

     

    Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

     

      (a) ¨ Broker or dealer registered under Section 15 of the Act;
      (b) ¨ Bank as defined in Section 3(a)(6) of the Act;
      (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act;
      (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940;
      (e) x An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
      (f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

      (g) x A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
      (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
      (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
      (j) ¨ A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

      If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J),  
      please specify the type of institution:    
             

    Item 4 Ownership
       
     

    See rows (9) and (11) of the cover pages to this Schedule 13G Amendment for the aggregate number of shares of Class A Common Stock and the percentage of the shares of Class A Common Stock beneficially owned by the Reporting Persons. The percentages used in this Schedule 13G Amendment are calculated based upon 87,396,972 shares of Class A Common Stock issued and outstanding as of November 9, 2022, as set forth in the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 and the 23,500,000 shares issued upon the closing of the transaction reported in the Company’s Prospectus, both filed with the Securities and Exchange Commission on November 9, 2022.

       
     

    See rows (5) through (8) of the cover pages to this Schedule 13G Amendment for the number of shares of Class A Common Stock as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

     

    CUSIP No. 14171W10313G/APage 6 of 7 Pages

     

    Item 5. Ownership of Five Percent or Less of a Class
       
      Not applicable.

       
    Item 6. Ownership of More than Five Percent on Behalf of Another Person
       
      No person other than the Reporting Persons and the Eminence Funds and SMAs is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the shares of Class A Common Stock held by the Eminence Funds and SMAs.  

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
       
      Not Applicable.

     

    Item 8. Identification and Classification of Members of the Group.
       
      Not Applicable.

     

    Item 9. Notice of Dissolution of Group.
       
      Not Applicable.

     

    Item 10. Certification

     

      Each of the Reporting Persons hereby makes the following certification:
       
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

    CUSIP No. 14171W10313G/APage 7 of 7 Pages

     

    SIGNATURES

    After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    DATE: February 14, 2023

     

      /s/ Ricky C. Sandler
      Ricky C. Sandler, individually, and as Chief Executive Officer of Eminence Capital, LP

     

    Get the next $CMAX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CMAX

    DatePrice TargetRatingAnalyst
    2/26/2024$1.50 → $7.50Buy → Hold
    Jefferies
    11/17/2023$5.00 → $1.00Buy → Neutral
    UBS
    11/10/2023$3.00 → $2.00Overweight → Neutral
    Piper Sandler
    3/17/2023$7.00 → $4.00Outperform → Market Perform
    TD Cowen
    9/7/2022$7.50Hold
    Truist
    1/7/2022$14.00Buy
    UBS
    10/20/2021$15.00Buy
    Jefferies
    9/13/2021$14.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $CMAX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CareMax Enters Into Agreement to Sell Core Centers' Assets

      ClareMedica Health Partners to become "Stalking Horse" Bidder to Acquire CareMax's Core Centers' Assets CareMax, Inc. (NASDAQ:CMAX, CMAXW)) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced that it has entered into a "stalking horse" purchase agreement with ClareMedica Health Partners ("ClareMedica"), a leader in value-based primary care serving patients in Florida, pursuant to which ClareMedica will acquire CareMax's core centers' assets including a vast majority of CareMax's operating clinics (the "Core Centers' Assets"). The transaction will be implemented pursuant to a previously announced prearranged chapter 11 plan support

      11/25/24 6:30:00 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Reaches Agreements to Sell Management Services Organization and Core Centers' Assets

      Revere Medical Enters into Agreement to Acquire CareMax's Management Services Organization Agreement in Principle Reached with "Stalking Horse" for Core Centers' Assets Sale Transactions to be Implemented Through an Expedited Prearranged Chapter 11 Plan Supported by 100% of CareMax's Secured Lenders CareMax Secures $30.5 Million in Debtor in Possession Financing to Support Operations and Continuing Provision of Healthcare Services Throughout Restructuring Process CareMax, Inc. (NASDAQ:CMAX, CMAXW)) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced it has entered into an agreement to sell its management services organization

      11/17/24 6:17:00 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Reports Second Quarter 2024 Results

      Second Quarter Medicare Advantage Membership of 104,000, up 1% year-over-year Second Quarter Total Revenue of $198.6 million, down 12% year-over-year CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the second quarter ended June 30, 2024. "Although our medical expense ratio continued to run higher than target levels, we were able to manage toward another quarter of sequential improvement in MER in the second quarter, and we continued to make progress against our clinical initiatives," said Carlos de Solo, Chief Executive Officer. Mr. de Solo continued, "Additiona

      8/9/24 5:30:00 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    SEC Filings

    See more
    • CareMax Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - CareMax, Inc. (0001813914) (Filer)

      11/25/24 6:35:08 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update, Financial Statements and Exhibits

      8-K - CareMax, Inc. (0001813914) (Filer)

      11/18/24 6:55:10 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • SEC Form NT 10-Q filed by CareMax Inc.

      NT 10-Q - CareMax, Inc. (0001813914) (Filer)

      11/13/24 4:56:07 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by CareMax Inc. (Amendment)

      SC 13G/A - CareMax, Inc. (0001813914) (Subject)

      2/14/24 7:36:14 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G filed by CareMax Inc.

      SC 13G - CareMax, Inc. (0001813914) (Subject)

      2/12/24 10:53:22 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13D/A filed by CareMax Inc. (Amendment)

      SC 13D/A - CareMax, Inc. (0001813914) (Subject)

      3/13/23 5:06:40 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    Leadership Updates

    Live Leadership Updates

    See more
    • Steward Health Care Appoints Rubén José King-Shaw Jr to Its Board of Directors

      Steward Health Care, the nation's largest physician-led health care network, today announced the appointment of Rubén José King-Shaw Jr to its Board of Directors. King-Shaw currently serves as Steward's Executive Vice President & Chief Strategy Officer, where he has led a number of critical strategic acquisitions and divestitures including the sale of Steward Health Choice Arizona and the significant merger of Steward's value-based Medicare business with Caremax (NASDAQ:CMAX). King-Shaw also chairs Steward's offshore captive insurance company, TRACO, which is domiciled in Panamá. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220

      7/7/22 5:12:00 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax, Inc. Announces Board Leadership Transition

      CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, today announced the appointment of Mr. Jose R. Rodriguez as Chair of CareMax's board of directors, to succeed Mr. Richard A. Barasch, who has resigned from the Board. Mr. Rodriguez has served as a member of CareMax's board of directors since June 2021 and previously served as CareMax's Lead Independent Director. Mr. Barasch will continue to serve as an advisor to CareMax's board of directors. "We are excited that Jose has agreed to lead CareMax's board of directors as we start our first full year as a public company. The board and I believe Jose's recognized leadership in

      2/7/22 4:30:00 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax, Inc. Appoints Beatriz Assapimonwait to Board of Directors

      CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, today announced that Beatriz Assapimonwait has been appointed as an independent member of the CareMax board of directors. Ms. Assapimonwait brings to CareMax 38 years of Medicare managed care experience, including a decade of experience as a leader in the Medicare markets in South Florida, North Florida, and Puerto Rico. Most recently, Ms. Assapimonwait served as the Regional President for Humana South Florida where she was responsible for developing market strategies and leading market operations. Before that, Ms. Assapimonwait was CEO of Family Physicians of Winter Park

      9/20/21 6:55:00 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CareMax downgraded by Jefferies with a new price target

      Jefferies downgraded CareMax from Buy to Hold and set a new price target of $7.50 from $1.50 previously

      2/26/24 7:26:58 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax downgraded by UBS with a new price target

      UBS downgraded CareMax from Buy to Neutral and set a new price target of $1.00 from $5.00 previously

      11/17/23 7:26:57 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded CareMax from Overweight to Neutral and set a new price target of $2.00 from $3.00 previously

      11/10/23 7:33:59 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    Financials

    Live finance-specific insights

    See more
    • CareMax Reports Fourth Quarter and Full Year 2023 Results

      Met 2023 Guidance for Medicare Advantage Membership and Total Revenue Year-end 2023 Medicare Advantage Membership of 111,500, up 19% year-over-year Full Year 2023 Total Revenue of $751.1 million, up 19% year-over-year Exploring Strategic Options to Maximize Value of Certain Assets and Generate Further Liquidity CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the fourth quarter and full year ended December 31, 2023. "In the fourth quarter, we began taking major steps with the goal of solidifying the long-term viability of our business," said Carlos de Solo, C

      3/18/24 6:55:00 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Reports Third Quarter 2023 Results

      Third Quarter Medicare Advantage Membership of 107,000, up 171% year-over-year Third Quarter Total Revenue of $201.8 million, up 28% year-over-year Reaffirming Full Year 2023 Revenue Guidance; Updating Full Year 2023 Medicare Advantage Membership and Adjusted EBITDA Guidance CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the third quarter ended September 30, 2023. "Tomorrow marks one year since the acquisition of our national MSO and nearly two and a half years of rapid growth in our patient and provider base. Over that period, we experienced fluctuations in o

      11/9/23 6:55:00 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Schedules Third Quarter 2023 Earnings Conference Call

      CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading value-based care delivery system, announced today that it will release its financial results for the third quarter 2023 before the opening of the financial markets on Thursday, November 9, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for international participants, and referencing conference ID 7874605. A live audio webcast and replay of the event will also be available on the "Events & Presentations" section of CareMax's investor relations website at ir.caremax.com. About CareM

      10/25/23 6:55:00 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Borkowski Edward

      3 - CareMax, Inc. (0001813914) (Issuer)

      10/2/24 5:03:58 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • SEC Form 3 filed by new insider Rundell Paul Brent

      3 - CareMax, Inc. (0001813914) (Issuer)

      6/20/24 4:18:15 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • Flynn James E converted options into 12,123 shares (SEC Form 4)

      4 - CareMax, Inc. (0001813914) (Issuer)

      11/21/23 6:09:00 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care